Ticker Details
Y-mAbs Therapeutics, Inc.
IPO Date:	September 17, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$391.22M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.59 | 3.24%
Avg Daily Range (30 D):	$0.02 | 0.23%
Avg Daily Range (90 D):	$0.06 | 1.33%

Institutional Daily Volume
Avg Daily Volume:	.27M
Avg Daily Volume (30 D):	M
Avg Daily Volume (90 D):	.55M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	246
Avg Trade Size (Sh.) (90 D):	290

Institutional Trades
Total Institutional Trades:	1,174
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$1.23M
Avg Institutional Trade (90 D):	$2.04M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.43M
Avg Closing Trade (30 D):	$1.23M
Avg Closing Trade (90 D):	$.83M
Avg Closing Volume:	65.51K

News

Sep 16, 2025 @ 12:41 PM SERB Pharmaceuticals Completes Acquisition of Y-mA... Source: Globe Newswire

Aug 26, 2025 @ 7:56 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Aug 8, 2025 @ 11:37 AM Y-mAbs (YMAB) Q2 Revenue Falls 14% Source: Jesterai

Aug 7, 2025 @ 10:44 PM $HAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde

Aug 5, 2025 @ 6:46 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.5	$-.07	$-.12
Diluted EPS	$-.5	$-.07	$-.12
Revenue	$85.39M	$19.53M	$20.9M
Gross Profit	$69.83M	$16.86M	$17.9M
Net Income / Loss	$-22.22M	$-3.24M	$-5.2M
Operating Income / Loss	$-26.65M	$-5.6M	$-6.54M
Cost of Revenue	$15.55M	$2.66M	$3M
Net Cash Flow	$-4.94M	$1.98M	$-6.92M
PE Ratio